Advanced Structure Analysis

Modulus invests significantly in obtaining unique, exclusive, and high-quality 3-dimensional drug target structures, allowing us to fully leverage our supercomputing technology platform and providing our portfolio with a unique advantage.

In addition to active efforts in pursuing target structures through protein crystallization, we are working closely with top-tier collaborators with state-of-the-art Cryo-EM capabilities, enabling us to determine structures for targets that were inaccessible through traditional crystallization approaches.

Our growing internal structural database contains our own novel and proprietary structures, as well as large number of non-public structures shared with us through our exclusive collaboration partners.